PanoramicaGraficoTecnicoNotizieSchermataTrader

Supernus Pharmaceuticals Inc/  US8684591089  /

NASDAQ
08/11/2024  22:00:00 Var. +0.2000 Volume Denaro01:04:15 Lettera01:04:15 Max Min
36.6000USD +0.55% 578,650
Fatturato: 13.09 mill.		 33.3000Quantità in denaro: 100 38.7300Quantità in lettera: 100 36.7800 35.8700
GlobeNewswire 28/08 Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
GlobeNewswire 19/08 Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
GlobeNewswire 06/08 Supernus Announces Second Quarter 2024 Financial Results
GlobeNewswire 01/08 Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
GlobeNewswire 23/07 Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call ...
GlobeNewswire 30/05 Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 23/05 Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epile...
GlobeNewswire 21/05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 12/05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 09/05 Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa St...
GlobeNewswire 08/05 Supernus Announces First Quarter 2024 Financial Results
GlobeNewswire 02/05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 01/05 Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
GlobeNewswire 24/04 Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call o...
GlobeNewswire 24/04 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 08/04 Supernus Provides Regulatory Update for SPN-830
GlobeNewswire 26/03 MannKind Announces CFO Transition
GlobeNewswire 06/03 Supernus to Participate in Two Upcoming Investor Conferences
GlobeNewswire 28/02 Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
GlobeNewswire 27/02 Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 13/02 Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Co...
GlobeNewswire 05/02 Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
GlobeNewswire 02/02 SAB Biotherapeutics Announces Executive Leadership Change
GlobeNewswire 08/11/2023 Supernus Announces Third Quarter 2023 Financial Results
GlobeNewswire 07/11/2023 Supernus to Participate in the Jefferies London Healthcare Conference